Related content

Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol

By Orvieto Raoul   Volodarsky Michael   Hod Eduard   Homburg Roy   Rabinson Jacob   Zohav Efraim   Anteby Eyal   Meltcer Simion  

Gynecological Endocrinology, Vol. 23, Iss. 8, 2007-08 ,pp. : 494-496

Informa Healthcare

Access to resources Recommend Favorite

Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone ((GnRH)) agonist and GnRH antagonist during cancer treatment in young females

By Potolog-Nahari Claris   Fishman Ami   Cohen Ilan  

Gynecological Endocrinology, Vol. 23, Iss. 5, 2007-11 ,pp. : 290-294

Informa Healthcare

Access to resources Recommend Favorite

Case report. High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization

By de Jong D  

Human Reproduction, Vol. 13, Iss. 3, 1998-03 ,pp. : 573-575

Oxford University Press

Access to resources Recommend Favorite

Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization–embryo transfer

By Doldi Nicola   Persico Paola   Di Sebastiano Francesca   Marsiglio Elena   Ferrari Augusto  

Gynecological Endocrinology, Vol. 22, Iss. 5, 2006-05 ,pp. : 235-238

Informa Healthcare

Access to resources Recommend Favorite

Ovarian hyperstimulation syndrome after using onadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications

By Kol S.   Lewit N.   ltskovitz-Eldor J.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1143-1144

Oxford University Press

Access to resources Recommend Favorite